Demyelinating diseases are a group of disorders of the nervous system that involve loss of the myelin sheath that normally surrounds the neurons. Demyelinating diseases can affect both the central ...

Damage to myelin, the protective sheath surrounding nerve fibers, impairs the brain's ability to transmit signals efficiently ...

Biopharmaceutical company Quantum BioPharma (QNTM) has seen its stock rocket up roughly 230% in the past month. The company holds a 25.71% ...

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...

The range of disorders thatcan mimic MS is vast; as the prototypical inflammatory demyelinating disorder, it may be confused with both unrelated demyelinating diseases (metabolic or inherited) and ...

The neurologist explains the link between Guillain-Barre Syndrome and paralysis, and the initial symptoms to watch out for.

Fatigue is also common. Inflammation is one common cause of damage to myelin, but other things can cause demyelination, including: ...

Chronic inflammatory demyelinating polyneuropathy (CIDP ... Vyvgart Hytrulo works by reducing the level of pathogenic (disease-causing) immunoglobulin G (IgG) antibodies in your bloodstream.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...

According to GlobalData, Phase III drugs for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP ... Its portfolio includes medicines for the treatment of cancer, rare diseases, multiple sclerosis ...

Empire is based at 40 Wall Street, New York, New York, United States of America. Empire has been engaged for a period of three months, effective February 7, 2025 (the “ Empire Agreement ”). Pursuant ...